Top Markets
#1 EXOD EXOD +22.08%
#2 XPIN Network XPIN Network +19.36%
#3 Geodnet Geodnet +17.32%
#4 BOOK OF MEME BOOK OF MEME +17.24%
#5 Bitway Bitway +16.76%
#6 The Black Bull The Black Bull +16.18%
#7 Derive Derive +15.68%
#8 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +15.67%
#9 SSV Network SSV Network +15.42%
#10 Bitcoin Cash Bitcoin Cash +15.34%
Coin of the day
EXOD EXOD
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Cortexyme, Inc. Cortexyme, Inc.

Cortexyme, Inc.

CRTX
Rangering i aksjer #25183
Cortexyme, Inc. is a clinical-stage biopharmaceutical firm committed to... Cortexyme, Inc. is a clinical-stage biopharmaceutical firm committed to pioneering new therapies for Alzheimer's and various other degenerative conditions. The company's primary investigational drug, atuzaginstat (also known as COR388), is an orally delivered, small molecule inhibitor engineered to cross the blood-brain barrier and target gingipain. This compound is currently in Phase II/III clinical trials, where it is being assessed for its potential use in individuals with mild to moderate Alzheimer's disease, as well as for tackling oral squamous cell carcinoma, periodontitis, and coronavirus infections. Established in 2012, Cortexyme, Inc. is headquartered in South San Francisco, California.
Aksjekurs
$1.95
Sist synkronisert: 2022-07-29
Markedsverdi
$52.48M
Endring (1 dag)
2.63%
Endring (1 år)
0.00%
Land
US
Handel Cortexyme, Inc. (CRTX)

Kategori

Healthcare
Inntekter for Cortexyme, Inc. (CRTX)
Inntekter i 2026 TTM: 0
Ifølge Cortexyme, Inc. sine nyeste økonomiske rapporter er selskapets nåværende resultat 0. I 2026 hadde selskapet et resultat på 0, lik resultatet i 2026, som var 0. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Cortexyme, Inc. fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US